We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$2.48B
Cap. Flow %
-27.43%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 3.09%
2 Consumer Discretionary 2.5%
3 Technology 1.62%
4 Financials 1.05%
5 Communication Services 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EYPT icon
701
PUT
EyePoint Inc
EYPT
$1.03B
$2.07M 0.02%
+220,300
New +$1.52M
NN icon
702
NextNav
NN
$1.79B
$2.06M 0.02%
135,478
-72,954
-35% -$936K
OCUL icon
703
PUT
Ocular Therapeutix
OCUL
$1.79B
$2.05M 0.02%
+220,900
New +$1.73M
GRPN icon
704
Groupon
GRPN
$1.05B
$2.05M 0.02%
61,282
-433,958
-88% -$11.1M
BAX icon
705
Baxter International
BAX
$13.5B
$2.04M 0.02%
+67,500
New +$2.05M
OTIS icon
706
PUT
Otis Worldwide
OTIS
$27.4B
$2.04M 0.02%
+20,600
New +$1.99M
HAL icon
707
CALL
Halliburton
HAL
$26.9B
$2.04M 0.02%
+100,000
New +$2.1M
AUPH icon
708
PUT
Aurinia Pharmaceuticals
AUPH
$1.91B
$2.04M 0.02%
240,500
-75,000
-24% -$601K
EGO icon
709
CALL
Eldorado Gold
EGO
$7.87B
$2.03M 0.02%
100,000
ABR icon
710
PUT
Arbor Realty Trust
ABR
$964M
$2.03M 0.02%
+190,000
New +$2M
FL
711
PUT
DELISTED
Foot Locker
FL
$2.02M 0.02%
+82,500
New +$1.5M
TRVI icon
712
CALL
Trevi Therapeutics
TRVI
$2.59B
$2.01M 0.02%
367,600
-756,400
-67% -$4.71M
SYF icon
713
Synchrony
SYF
$24.7B
$2M 0.02%
+30,000
New +$1.68M
LRMR icon
714
Larimar Therapeutics
LRMR
$397M
$1.99M 0.02%
+689,290
New +$1.6M
BHF icon
715
Brighthouse Financial
BHF
$3.56B
$1.99M 0.02%
+37,000
New +$2.08M
BTI icon
716
British American Tobacco
BTI
$131B
$1.99M 0.02%
+42,000
New +$1.86M
FCX icon
717
CALL
Freeport-McMoran
FCX
$90B
$1.98M 0.02%
45,700
-225,700
-83% -$8.57M
NN icon
718
PUT
NextNav
NN
$1.79B
$1.98M 0.02%
130,000
-85,000
-40% -$1.09M
APH icon
719
Amphenol
APH
$198B
$1.98M 0.02%
20,000
+12,000
+150% +$981K
LQDA icon
720
CALL
Liquidia Corp
LQDA
$7.48B
$1.97M 0.02%
+158,500
New +$2.35M
MUR icon
721
CALL
Murphy Oil
MUR
$5.7B
$1.97M 0.02%
87,500
+7,500
+9% +$167K
ADMA icon
722
ADMA Biologics
ADMA
$1.96B
$1.97M 0.02%
+108,000
New +$2.2M
INDA icon
723
CALL
iShares MSCI India ETF
INDA
$6.89B
$1.95M 0.02%
+35,000
New +$1.87M
ALLT icon
724
Allot
ALLT
$372M
$1.93M 0.02%
226,146
-44,435
-16% -$320K
ARGX icon
725
PUT
argenx
ARGX
$53.4B
$1.93M 0.02%
3,500
-6,000
-63% -$3.48M

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.